We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Federal Signal
FSS
$7.63B
| $1.68M | ﹤0.01% |
121,646
+31,868
| +35% | +$480K |
|
1652
AMC Entertainment Holdings
AMC
$2.52B
| $1.68M | ﹤0.01% |
5,340
+2,828
| +113% | +$903K |
|
1653
Hilton Grand Vacations
HGV
$3.59B
| $1.68M | ﹤0.01% |
+58,537
| New | +$1.67M |
|
|
RPT
1654
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $1.67M | ﹤0.01% |
119,237
+7,962
| +7% | +$123K |
|
1655
Customers Bancorp
CUBI
$2.66B
| $1.67M | ﹤0.01% |
52,975
+18,352
| +53% | +$624K |
|
1656
Encore Capital Group
ECPG
$2.02B
| $1.66M | ﹤0.01% |
54,010
+13,097
| +32% | +$412K |
|
|
PMC
1657
DELISTED
PharMerica Corporation
PMC
| $1.66M | ﹤0.01% |
71,084
+16,784
| +31% | +$414K |
|
1658
ePlus
PLUS
$2.42B
| $1.65M | ﹤0.01% |
48,876
+15,912
| +48% | +$488K |
|
|
AEGN
1659
DELISTED
Aegion Corp
AEGN
| $1.65M | ﹤0.01% |
72,032
+17,302
| +32% | +$398K |
|
|
KNL
1660
DELISTED
Knoll, Inc.
KNL
| $1.65M | ﹤0.01% |
69,315
+1,566
| +2% | +$38.7K |
|
1661
LendingTree
TREE
$447M
| $1.64M | ﹤0.01% |
13,115
+3,934
| +43% | +$449K |
|
1662
Cato Corp
CATO
$68.3M
| $1.64M | ﹤0.01% |
74,593
+16,277
| +28% | +$406K |
|
1663
Groupon
GRPN
$1.05B
| $1.64M | ﹤0.01% |
20,835
+606
| +3% | +$46.7K |
|
1664
Red Robin
RRGB
$145M
| $1.63M | ﹤0.01% |
27,922
+7,138
| +34% | +$358K |
|
|
UNVR
1665
DELISTED
Univar Solutions Inc.
UNVR
| $1.62M | ﹤0.01% |
52,967
+3,601
| +7% | +$108K |
|
1666
Ethan Allen Interiors
ETD
$570M
| $1.62M | ﹤0.01% |
52,965
+13,907
| +36% | +$422K |
|
|
FCH
1667
DELISTED
Felcor Lodging Trust
FCH
| $1.62M | ﹤0.01% |
215,707
+8,924
| +4% | +$67.7K |
|
1668
Theravance Biopharma
TBPH
$874M
| $1.62M | ﹤0.01% |
43,966
+3,142
| +8% | +$100K |
|
1669
PetMed Express
PETS
$41.7M
| $1.62M | ﹤0.01% |
80,304
+6,003
| +8% | +$127K |
|
|
AMAG
1670
DELISTED
AMAG Pharmaceuticals
AMAG
| $1.61M | ﹤0.01% |
71,610
+18,680
| +35% | +$447K |
|
|
BNCN
1671
DELISTED
BNC Bancorp
BNCN
| $1.61M | ﹤0.01% |
46,080
+1,874
| +4% | +$65K |
|
|
NAV
1672
DELISTED
Navistar International
NAV
| $1.61M | ﹤0.01% |
65,497
+3,701
| +6% | +$102K |
|
|
ASRT
1673
DELISTED
Assertio
ASRT
| $1.61M | ﹤0.01% |
2,139
+572
| +37% | +$580K |
|
1674
Sonic Automotive
SAH
$2.9B
| $1.61M | ﹤0.01% |
80,373
+13,863
| +21% | +$310K |
|
|
BFS
1675
Saul Centers
BFS
$836M
| $1.61M | ﹤0.01% |
26,078
+7,288
| +39% | +$464K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.